Skip to content

Posts from the ‘Capital Product Partners (CPLP)’ Category

Week 2015: Maybe its just a bear market

Portfolio Performance

week-215-yoyperformanceweek-215-Performance

 

See the end of the post for the current make up of my portfolio and the last four weeks of trades

Monthly Review and Thoughts

I don’t flash sensational headlines about bear markets for the sake of getting attention.  I get about 100-150 page views a day and given the frequency and technicality of my writing I don’t expect that to increase materially regardless of the headline I post.

When I raise the question of whether we are in a bear market, its simply because even though the US averages hover a couple of percent below recent highs, the movement of individual stocks seems to more closely resemble what I remember from the early stages of 2008 and the summer of 2011.

A breakdown of the performance of the Russell 2000, which is where a lot of the stocks I invest in reside, was tweeted out this week by 17thStrCap and I think illustrates the pain quite well:

us market

The Canadian stock averages have been made respectable by Valeant and not much else. In a Globe & Mail article appropriately capsulizing my comment here called “The market is in much worse shape than the TSX index suggests” the following comparison was made between the TSX Composite and an equal weighted version of it that dampens out the Valeant effect.

tsxperformance

When the Federal Reserve ended its quantitative easing program last year I was concerned that the market might revert back to the nature it had demonstrated after first two QE endeavors.  But for a number of months that didn’t happen.  Stocks kept moving; maybe not upwards at the speed they had previously but they also did not wilt into the night.

I am starting to think that was nothing more than the unwinding of the momentum created by such a long QE program.  Slowly momentum is being drained from the market as the bear takes hold.

A week late

I am a week late getting to this update.  We were on vacation last week, which made it tough to write.  As well I was in no mood to ruin my vacation and write with my portfolio going through significant perturbations to the downside.

It is frustrating to see my portfolio doing poorly.  My investment account is being saved by two things:

  1. Shorts
  2. US stocks in Canadian dollars

As I mentioned last month I have had a number of technology shorts, some shorts on Canadian banks and mortgage providers, and hedges on energy and small caps via the XOP and IWM.  I actually took a bunch of the tech shorts off in the last few days for the simple reason that they are up so much.  I had some decent gains from INTC, SNDK, MU, ANET AVGO, RAX, HIMX and TSM.  I also ended my multi-year short on YELP.

I am covering my shorts because with earnings season over I think there could be a counter rally resulting from the news vacuum.   The China collapse angle has been beaten up and priced in; I could see the perception shifting towards the positive outcomes of the stimulus. And I’ve read that Apple is increasing orders for the iPhone 6s and 6s+ which may or may not be warranted (I suspect not) but could lift tech results in the short term.

I would put these shorts back on if the stocks recovered.  But I don’t feel like I know enough about tech to be pressing my luck on the names.  And as I reduce my long portfolio and raise cash, I feel less need to have what feel like stretched shorts to hedge those positions.

Without the benefit of short hedging this blog’s online tracking portfolio has done worse.  I’m down about 5.6% from a brief peak I hit in mid-July (when the tankers were at their highs) and I am essentially running flat for the last 4 months.

At the center of my frustration are tankers, airlines, small caps and the REITs.  So pretty much everything.  Let’s talk about each.

The Tankers

With oil oversupplied and refiners working at record capacity producing gasoline, jet fuel and heating oil, one would expect that the market would turn to crude and product tankers as a natural beneficiary.

No such luck.

The recent moves by my favorite tanker plays: DHT Holdings, Ardmore Shipping and Capital Product Partners, have been to the downside.  There was a brief move up towards the end of July that coincided with earnings (which were outstanding) but it was quickly unwound and now we are back to levels seen a few months ago.  While I sold some along the way up, it wasn’t (and isn’t) ever enough.

Ardmore Shipping

Particularly with the product tankers (specifically Ardmore Shipping), I just don’t get why the behavior is so poor.  I found it difficult to come away from their second quarter conference call with anything but an extremely bullish take on the company’s prospects.

The product market is benefiting from extremely strong refinery utilization and strong demand for products.  It is also benefiting from the move by Middle East nations to add refining capacity with the view of exporting finished products.

Ardmore had earnings per share of 30c.  They achieved those earnings with 18.4 ships. By the end of the year, once all of their newbuild fleet is delivered, the company expects to have 24 ships.  If newbuilds had been operating in the second quarter, earnings would have been 43c for the quarter.

In the second quarter Ardmore saw spot rates of $22,400 TCE.  So far in the third quarter spot rates are up again to $23,500.  At current $23,500 spot rates and with 12 MR’s in the spot market, EPS would be $1.85.  The stock has been trading at around $13.

Yet the stock sells off.

DHT Holdings

Likewise, I couldn’t believe it when DHT Holdings traded down to below $7 on Wednesday.  At least the crude tanker market makes some sense in terms of rates.  Voyage rates have come off to $40,000 TCE for VLCC ships.  This is seasonal and if anything rates have held up extraordinarily well during the slow third quarter.

DHT stated on its conference call that they had more than 50% of their third quarter booked at $80,000 per day.  The company has a net asset value of around $8.50 per share.

While I already had a pretty full position heading into the last move down I held my nose and added more at $7.15 (i never catch the lows it seems).  I’m not holding these extra shares for long though.  In this market having an over-sized position in anything seems akin to holding an unpinned grenade.

The Airlines

While Hawaiian Airlines has been an outperforming outlier, responding well to strong earnings, Air Canada has languished.  The stock got clobbered after the company announced record earnings and great guidance.

Air Canada reported 85c EPS and $591 million EBITDAR.  In comparison, BMO had been expecting 90c EPS and $618mm EBITDAR and RBC had been expecting 77c EPS and $558mm EBITDAR.

The story here really boils down to the Canadian economy.

Both WestJet and Air Canada are increasing capacity.  The market is worried that they are going to flood a weak market and pressure yields.  On the conference call Air Canada addressed the concern by pointing out that A. the capacity they are adding is going into international routes and B. they have yet to see anything but robust demand for traffic.

What’s crazy is that while investors have responded negatively, analysts have been bullish to the results.  I read positive reports from RBC, TD and BMO.   Only Scotia, which I don’t have access to, downgraded the stock on concerns about no further upside catalysts.

Its rare to see multiple upgrades accompanied by a 7% down move in a stock.  I would love to see one of the darling sectors, tech or biotech, respond in such a manner.

So the analysts are bullish and the company is bullish but right now the market doesn’t care.  As is the case in general, the market cares about what might happen if some negative confluence of events comes to fruition.  And it continues to price in those worries.

Its just a really tough market.

Trying to find something that works

Another contributor to my poor performance has been that what has worked over the last five years is working less well now.

In particular, over the last give years I have followed a strategy of buying starter positions in companies where I see some probability of significant upside.   In some cases I will buy into companies that do not have the best track record or are not operating in the most attractive sectors.  But because the upside potential is there I will take a small position and then wait to see what happens. If the thesis begins to play out and the stock rises, I add.  If it doesn’t I either exit my position or, in the worst case, get stopped out.

This has worked well, with my usual result being something like this.  I have a number of non-performers that I end up exiting for very little gain or loss, a few big winners, and a couple of losers where I sell after hitting my stops.

I’ve had a lot of winners this way over the last few years: Mercer International, Tembec, MGIC, Radian, Nationstar, Impac Mortgage (the first time around in 2012), YRC Worldwide, Pacific Ethanol, Phillips 66, Nextstar Broadcasting, Alliance Healthcare Yellow Media and IDT Corp are some I can think of off-hand.  In each case, I wasn’t sold on the company or the thesis, but I could see the potential, and scaling into the risk was a successful strategy of realizing it.

Right now the strategy isn’t working that well.  The problem is that the muddling middle of non-performers is being skewed to the downside.  Instead of having stocks that don’t pan out and get sold out at par, I’m seeing those stocks decline from the get-go.   I am left sitting on either a 5-10% loss or getting stopped out at 20% before anything of note happens.  Recent examples are Espial Group, Hammond Manufaturing, Versapay, Higher One Education, Willdan Group, Acacia Research, Health Insurance Innovations and my recent third go round with Impac Mortgage.

All of these stocks have hair.  But none has had anything materially crippling happen since I bought them.  In the old days of 2012-2014, these positions would have done very little, while others, like Patriot National, Intermap, Photon Control, Red Lion Hotels and most recently Orchid Island would run up for big gains and overall I’d be up by 20% or so.  Instead this year the winners still win, albeit with less gusto, but its the losers that are losing with far more frequency and depth.

So the question is, if what has worked is no longer working, what do you do?

You stop doing it.

I cleaned out my portfolio of many of the above names and reduced a couple of others by half.

So let’s talk about some of what I have kept, and why.

Health Insurance Innovations

HIIQ announced results that weren’t great but the guidance was pretty good.  Revenue came in at $23 million which is similar to Q1.  In the first quarter the company had been squeezed by the ACA enrollment period, but in the second quarter this should have only impacted April.  So I had been hoping revenue would be a touch better.

The guidance was encouraging though.  The company guided to $97-$103 million revenue for the year which suggests a big uptick in the second half to around $28 million per quarter.  In my model, I estimate at the midpoint they would earn 40c EPS from this level of revenue if annualized.

Also noted was that ACA open enrollment would be 90 days shorter next year, which should mitigate the revenue drag in the first half of the year.  And they appear to be doing a major overhaul of management – bringing on people from Express Scripts (new president), someone new to evaluate the web channel and a number of new sales people.

Its been a crappy position for me but I don’t feel like there is a reason to turf it at these levels, so I will hold.

Impac Mortgage

As usual Impac’s GAAP numbers are a confluence of confusion.  The headline number was better than the actual results because of changes to accretion of contingent expense that they incurred with the acquisition of CashCall.

The CashCall acquisition had contingent revenue payout and that payout expectation has decreased leading to lower accretion via GAAP.  Ignoring accretion the operating income was around $8 million which was less than the first quarter.

The decline was mostly due to lower gain on sale margins, which had declined to 186 bps from 230 bps.

While origination volumes were up 8% sequentially (see below) I had been expecting better.  The expansion of CashCall into more states was slower than I expected.  In the second quarter CashCall was registered in 19 states.  I actually had thought that number was 29.

q2volumesBy the third quarter CashCall is expected to be compliant in 40 states.  And really that is the story here.  Volume growth through expansion.

CashCall is a retail broker dealing primarily with money-purchase mortgages (mortgages to new home owners).  Therefore Impac is not as dependent on refinancing volumes as some other originators.

While it was not a great quarter the company still earned 70c EPS.  Its lower than my expectations but in absolute terms not a bad number.  On the conference call they said that Q3 margins looked better than Q2, and while July production was only about $700mm, they expected better in August-September as the pipeline was large.

I made a mistake buying the stock at $20 on the expectation of a strong second quarter.  But I think at $16 its reasonable given earnings power that should exceed $3+ EPS once CashCall is operating nationwide.

PDI Inc

The response to the PDI quarter is indicative of the market.  The company released above consensus earnings on Thursday along with news that their molecular diagnostic products were being picked up by more insurers.  In pre-market the stock was up 20% and it looked like we were off to the races.

It closed down.

Recall that PDI operates two businesses.  They have a commercial services business where they provide outsourced sales services to pharmaceutical companies looking to market their product.  And they have the interpace diagnostics business, which consists of three diagnostic tests: one for pancreatic cysts and two for thyroid cancer.

I suspect that the market decided to focus on the one negative in the report: reduced guidance for interpace revenues from $13-$14 million to $11-$12 million.  The guidance reduction was caused by a delay in receivables from some customers.  The metric by which to judge the growth of the actual operations, molecular diagnostic tests, increased from 1,650 in the first quarter to 2,000 in the second quarter.

But in this market you gotta focus on the negative.  At least on Friday.

Patriot National

When I bought Patriot they were a new IPO whose business was a platform that allowed them to procure and aggregate workers compensation policies for insurance carriers.  They sign a contract with a carrier for a bucket of policies with particular characteristics and then distributed that to their pool of agents, collecting a fee in return.

But over the last couple of months Patriot seems to be expanding that role to something more holistic.  Among their nine acquisitions in the past six months is an insurance risk management firm, an auditing and underwriting survey agency, an insurance billing solution platform and a beneits administration company for self-funded health and welfare plans nationwide.

Patriot describes themselves in their latest presentation as follows:

whattheyarePatriot has shown solid growth since their IPO, both through their roll-up strategy of small insurance businesses and organically.  They have increased their carrier relationships from 17 to 82.  They are expanding their relationship with a few big carriers like AIG and Zurich.  They have grown their agent pool from 1,000 to 1,750.

I’m not really sure what it was about the second quarter that caused the stock to sell-off like it has.  It was down 16% at one point on Wednesday, which is about the same time I tweeted that this is crazy and pulled the trigger.  I suspect its simply another case of a bad market, a run-up pre-earnings and a release that didn’t have anything clearly “blow-outish” about it.

Nevertheless the company provided guidance along with its results and for 2016 predicts 37% revenue growth and 55% earnings growth.  These numbers make no allowances for further accretive acquisitions, which undoubtedly will occur.

The stock trades at 6.5x its 2016 EBITDA multiple.  From what I can tell its closest peers trade at around 10x, and they aren’t growing at a pace anywhere near Patriot.  As I said I added under $16 and would do so again.

Orchid Island

I have followed Orchid Island for a long time having been an investor in its asset manager, Bimini Capital, in 2013.  I never bought into Orchid though; it seemed small, it always trade around or above book value and being an mREIT it seemed that you had to have more of an opinion on the direction of rates than I have had for a while.

But when the stock got below $8, or a 30%+ discount to book value, it just seemed to me like the opportunity was too ripe to pass up.

There have been a number of good SeekingAlpha articles by ColoradoWelathManagementFund on Orchid where he describes the MBS investments and also the Eurodollar hedges.  These hedges, which require a different GAAP accounting then other more commonly used hedges, seem to be at least partially responsible for confusing the market and leading to the massive discount to book.

However I don’t plan to wait this out until book value is realized.  When the stock hits double digits again I expect to be pulling the trigger.

Higher One Education

I bought back into Higher One after it got clubbed down to $2.20, where it seemed to be basing.  Upon buying the stock was promptly clubbed down again to below $2.

Like many other names I am not sure if the clubbing is warranted.  The company’s second quarter results were better than my expectations.

Adjusted EBITDA in the second quarter came in at $8 million versus $7.2 million in Q2 2014.  While the disbursement business EBITDA was down, both payments and analytics were up (46% and 38% respectively).  EPS was 8c which again was better than last year.

They lost 6 clients representing 86,000 signed school enrollment (SSEs), signed 4 new clients with 16,000 SSEs and renewed 59 clients with 675,000 SSE’s.  Their total SSEs were 5mm at the end of Q2.  Given the headwinds in the industry, Higher One is holding their own.

The overhang in the stock is because the DOE proposed new rules that ONE and others are pushing back on, with the biggest issue being that you can’t charge fees for 30 days after deposits.  From their conference call:

The way the rule is proposed every time there is a disbursement made into the students accounts, we’d have to freeze all fees for 30 days.

This of course would severely impair Higher One’s ability to be profitable with these accounts.

On Friday after writing this summary I decided to sell Higher One.  I’m waffling here.  I like the value but don’t like the uncertainty and if the market can knock it down to $1.90 then why not $1.50?  Uncertainty reigns king.  I might buy it back but its difficult to know just how low a stock like this can go.

My Oil Stocks

I’ve done a so-so job of avoiding the oil stock carnage of the last few months.  After the first run down in the stocks I added a number of positions in March and ran them back up as oil recovered to the $60’s.  Then oil started dropping again and in May I began to sell those stocks.

oiltweetBy mid-June I was out of all my positions other than RMP Energy.  By July I had reduced RMP Energy down to about a percentage weighting in my portfolio.

So far so good.

Unfortunately I started buying back into the oil names in mid-July, which was too early.  I bought Jones Energy in the mid to high-$7s but sold as it collapsed into the $6’s.  I tried to buy RMP again at $2.20 but got pushed out as it fell to $2.  I bought Baytex and Bellatrix which was just stupid (I sold both at a loss).  I’ve probably given back half of the profits I made on the first oil ramp.

In this last week I made another attempt but I am already questioning its efficacy.  I took small positions in RMP Energy and Jones Energy and a larger position in Granite Oil.  The former two have done poorly, while the latter had an excellent day on Friday that provides some vindication to my recent endeavors.

One thing I will not do with any of these names is dig in if the trend does not turn.  I’ve learned that commodity markets can act wildly when they are not balanced, and the oil market is not balanced yet.  So its really hard to say where the dust settles.

Even as I write this I wonder if I should not have just waited for a clear turn to buy.

These positions are partially hedged in two ways.  First, I shorted XOP against about a quarter of the total value of the positions.  And second by having so much US dollar exposure (still around half my account) as a Canadian investor they act as a bit of a counter-weight to the wild moves I can see from currency changes.

Jones Energy

One of the interesting things happening right now is that natural gas production is flattening, in many basins it’s declining, and yet no one cares.  When natural gas first went to new lows in 2012 many pointed to the declining natural gas rig count, believing prices would quickly bounce back.  They didn’t, in part because of the associated gas coming from all the liquids rich plays.

With the oil collapse much of the drilling in those liquids rich plays is no longer as attractive.  You have to remember that even as oil has fallen, natural gas liquids like propane and butane have fallen even further (ethane, which is the lightest of the liquids, is now worth no more than natural gas).  Many producers that were labeled as oil producers, because they produced liquids, really produced these lighter liquids that are now trading at extremely depressed levels.  Drilling in light-liquids rich basins (the Marcellus but also the Permian and parts of the Eagleford) has declined precipitously, and with it all of the associated gas being produced.

Meanwhile much needed propane export capacity is on the horizon and expected to arrive en-masse in 2016.

Jones Energy has too much debt (around $770 million net) but they also have oil and natural gas that take them out into 2018.  I think they are a survivor.  They have reduced their drilling and completion costs in the Cleveland from $3.8 million to $2.6 million.  They actually increased their rigs in the Cleveland in June, though I have to admit that might be dialed back again with the prices declining.  I bought back into the stock for the third time this year when it was clobbered on what seemed to be pretty good earning results (a beat and guidance raise).  Its a play on oil, but also on falling natural gas production, as natural gas makes up 43% of production and much of the associated liquids are light.

RMP Energy

I think that the miserable performance of this stock is overdone, but I have thought that for some time and down it continues to go.  RMP gets punished over and over again for essentially the same concern – Ante Creek declines.  This latest pummeling seems to have been precipitated by the disclosure that August volumes at Ante Creek were around 8,500 boe/d.   This is a decline from April volumes of 12,200boe/d but similar to end of June volumes.  Below is a chart from Scotia that details Ante Creek production:

antecreekvolumes

The April increase coincided with the new gas plant.  The subsequent fall was because the company drilled no new wells in the second quarter.  That production has stabilized from June to August without any new wells being drilled is encouraging.

But the market sees it differently.

Lost in the shuffle (with nary a mention in any of the reports I read) is that RMP has reduced its drilling and completion costs by 30% and that operating expenses were down from $5.26/boe to $3.89/boe.  Also forgotten is that the company is experiencing positive results at Waskahigan with it new frac design.

RMP trades at about 2x Price/cashflow and has debt of about 1.35x expected 2015 cash flows.  Its not levered like many peers and its not expensive.  These constant concerns about Ante Creek need to be priced in at some point.

Granite Oil

Of the three names I own, this is the one I am going to stick with the longest.  Granite has a $150 million market capitalization and $50 million of debt.  Their asset is a large position in the Alberta Bakken (350,000 net acres).  They can drill 240MBBL wells that are 98% oil for $2.8 million per well.

And they are beginning a gas injection EOR scheme that is showing promising results.  Below is company production as gas injection has increased.

alberta-bakken-eorThe results are well above expectation and show minimal decline even as the number of wells drilled has only increased marginally.

The result is some pretty strong economics even at lower oil prices.

economics

Granite management had been loading up on shares in the $4’s.  I did too.  The company announced earnings on Friday and is probably the only oil company to announce a dividend increase.  Like I said, this will be the last oil position to go for me.

Portfolio Composition

As I’ve said a number of times in the past, I sometimes forget to mimic my actual trades with the online RBC portfolio I track here.  After a while these differences get too out of whack and I have to re-balance.  I did some of that on Friday, and so the transactions on that day are simply me trying to square up position sizes.  I don’t have things quite right though; the cash level of my online portfolio is negative while my actual investment account is about 15% cash.  I looked at why this is and its the contribution of a number of positions that are all slightly larger in the online portfolio than they should be.  I didn’t have time to adjust everything exactly so I’ll just try to reduce this discrepancy naturally over time.

Click here for the last five weeks of trades.

week-215

 

Week 210: All about the 5-baggers

Portfolio Performance

week-210-yoyperformance

week-210-Performance

See the end of the post for the current make up of my portfolio and the last four weeks of trades

Monthly Review and Thoughts

A few weeks ago I was talking to someone who works at a large fund.   He was telling me about a retail clothing chain that their fund was interested in.  To help evaluate the opportunity, they commissioned a research firm to canvas and scout locations across the country.

That is amazing intel.  It is also wholly impossible for me to replicate.

I generally have a pretty good idea about a business before I buy into it.  I do a lot of work up front, far more than the highlights that go into these posts.  But I’m always left with elements that are uncertain.   For an individual investor with access to limited information and with limited time, certainty about one’s beliefs is more hubris than reality.

In the face of such disadvantages, my strategy is to take smallish positions and add to them if they begin to work out inline with my expectations.  If they don’t, I cut them.

By keeping my positions small until they start working and cutting my losses before they get big I guard against the big hit to my portfolio.  On the winning side of the ledger I generally end up with a similar number of winners that cancel out the losers.  But I also end up with 2 or 3 big winners that lead to out-performance.

It’s the 5-baggers that make the engine go.

Another portfolio year has passed (I started writing this blog on July 1st 2011) and you can see from the results that the last year was not as good as the previous few.  I still did better than the market, but I didn’t do that great.

In part the under-performance was caused by not sticking to my rules.  I have already rehashed my failures with Bellatrix and other oil names in past posts so I won’t go into that again here.

But I also attribute it to my lack of “5-baggers”.  I haven’t had a big winner in the last 52 weeks.  I’ve had a lot of good picks (Air Canada, Axia NetMedia, PNI Digital, Extendicare, Radcom, Rex American, the second go around with Pacific Ethanol and so on) but only one true double and nothing that tripled or quadrupled.

Realizing how important multi-baggers are I’m sending myself back to the drawing board.  I’m not sure why I’ve failed to discover the big movers over the last year.  But I suspect that it is at least partially due to ignorance of the sectors that have had the momentum.

Up until recently I never owned a bio-tech.  I’ve stayed away from technology in all but a few exceptions.  I’ve only been in healthcare on a couple of occasions (one of those being Northstar Healthcare, subsequently Nobilis Health Corp, which I rather amazingly sold last October, at no gain or loss, literally days before it began a climb from $1.20 to over $10 in thee next six months).  Yet these sectors are where the big winners have been.

My attitude towards these and other outperforming sectors is going to change.  I have invested in a couple of bio-techs and in technology (shorts mind you, as I will explain later) and in the last couple of months.  More new ideas will follow.

What I Sold

Usually I discuss my new positions next.  While I have a couple of these, they are not significantly sized and my actions have been more weighted to the sell side of the ledger, so it seems appropriate to discuss what I sold first.

As I tweeted on a couple of occasions I have been skittish about the market over the past month and a half.  I sold out of some positions and reduced others when Greece went on tilt and announced a referendum two weeks ago.

Since that time as my worries have subsided I have bought some of those positions back. It doesn’t look like an immediate contagion is upon us, which was my main concern.  Still I’m keeping a healthy amount of cash (20%) and where I can I am short a number of stocks.

In what turned out to be an unexpected consequence of my recent research expansion, over the past month I spent a lot of research hours looking at short opportunities. Trying to take more of an interest in tech, I read through reports describing the state of business and dynamics at play in everything from telecom infrastructure to smartphone.  As I did I felt most of the near term opportunity was on the short side, and so I took positions there.

My tech shorts have been based on three-fold expectations: PC sales are declining faster than consensus, smart phone sales will grow slower than consensus, and rumors that the big data build out by cloud providers has been overdone will prove to be true and future spending will be scaled back.  Without going into the individual names, I’ve stuck mostly with the big players and mostly with semi-conductor providers, which seem to be the most susceptible to spending downturns.

I think however that this play has almost run its course.  I have been taking off some positions heading into earnings (for example I was short Micron going into their June quarter but took it off the day after earnings were announced), and plan to exit my remaining positions as earnings are released.  I don’t like to hold short positions too long.

While I have yet to take any short positions in healthcare, I get the feeling that the recent merger mania may be leading to valuations that prove difficult to justify once the feeding frenzy subsides.  I note that a top pick of Jerome Haas, who I have followed and found to be a solid thinker, was a short on Valeant Pharmaceuticals.

In my online portfolio, in which I cannot short, I sold out of my gold mining shares, my oil stock shares, some of my tanker shares (Euronav and Frontline), a hotel play (Red Lion), reduced my airline exposure in both Air Canada and Hawaiian Holdings as well as my Yellow Pages and Enernoc positions.

I also sold out of DirectCash Payments, though I subsequently added the position back later (at about the same price).  I really want to hold this one through earnings because its been beaten down so far and I still have doubts as to whether the first quarter is the secular harbinger that the market seems to think it is.  In the turned out to be an unexpected consequence of my recent research expansion

Similarly, while I sold out of RMP Energy, I bought it back (at a lower price) because I want to see their quarter before giving up on the stock.  Like DirectCash Payments, I question whether results will be as dire as the market suggests. In the same segment of his BNN appearance Haas also made DirectCash Payments another top pick.

I only added to a couple of positions in the last month.  Patriot National continues to execute on their roll-up strategy, buying up smaller insurers at accretive multiples.  The stock is up 40% from my original purchase (though in the online portfolio I forgot to add it when I originally mentioned it so its up somewhat less there) and I decide to add to the position since its working out.

Second, I added to my position in Capital Product Partners on what I believe is unwarranted selling on Greece.  The company is incorporated in the Marshall Islands, does not pay Greek taxes but does have offices in Greece, which is at the heart of the sell-off.  A scan of the company’s annual filings shows that their exposure to Greece is potentially some deposits in Greek banks and the risk that one or more of their subsidiaries could face higher taxes.  I don’t think that correlates to the 20% plus sell-off in the share price.

I also added two new positions to my portfolio.

Intermap

I have followed Intermap for years.  Its a company that my Dad owned. While it always held out the promise of a significant revenue ramp Intermap could never quite figure out how to monetize their world class geo-spatial data.

Then, a couple of weeks ago, the company signed a large contract with unnamed government for the implementation of a National Spatial Data infrastructure program.

For years Intermap was primarily a mapping services provider.  They owned 3 Lear jets equipped with radar technology that scanned and mapped large swaths of terrain.  They would land contracts to map out a country or region and be paid for providing that data.

The company always kept the rights to their mapping data and, over time, Intermap compiled a database of geospatial data for a large part of the earth.   This spatial database became a product called NextMAP.   The database can be accessed through commercially available GIS software like ArcGIS or web browser apps developed by the company. Customers can license either parts of or the entire NextMAP database for their use.

The latest version of the database, called NextMAP World 30, is “a commercial 3D terrain offering that provides seamless, void free coverage, with a 30meter ground sampling distance, across the entire 150 million km2 of the earth’s surface.”

Intermap has always had a leading technology.  But they have struggled with coming up with profitable ways of marketing that technology.   Over the last three years the company has been working on applications that can be layered over their basic mapping data.  They have a program for analyzing the risk of fires and floods (InSite Pro), a program for managing hazardous liquid pipeline risk (InSite Pro for Pipelines) and a program for assessing outdoor advertising locations (AdPro).

None of these niche solutions have resulted in significant revenue to the company.

The carrot has always been that they land a large government contract for the full implementation of a geo-spatial solution for the country.  Most investors have given up on this ever happening, but then it did.

The announced contract is for $125 million over two years, during which time Intermap will implement the infrastructure solution.  This will be followed by an ongoing maintenance contract valued at $50 million over 18 years.

When I saw the number on the contract I knew immediately that the stock would jump significantly.  Including warrants and options Intermap has 127 million shares outstanding.  So at the closing price the night before the deal was announced the market capitalization was around $10 million.  When it opened around 25 cents I figured the upside was only about half priced in, so I jumped aboard.

The implementaton of a full geo-spatial solution as per the contract will involve the implementation of the company’s Orion platform, which includes the company’s NextMAP data integrated with other relevant third party data and with applications for accessing and analyzing the data.   The platform will be used to help with decision making with infrastructure planning, weather related risks, agriculture, excavation, and national security.  Because this is basically a new business for the company, its difficult to peg margins or profitability.  So I’m not going to try.

Nevertheless, just based on the rough assessment of what $125 million in revenue would mean, at this point, with the current stock price of 50 cents the contract is probably mostly priced into the stock.  I maybe should have sold on the run-up to 60 cents, but I decided not to.

The company has suggested in the past that they have a number of RFPs in the works and some of those they have already won but cannot announce until funding is secured.  The upside in the shares is of course a second contract. That could happen next week or next year.  Its impossible to predict.

The other consideration, and something I have always wondered about, is why some large company doesn’t pick up Intermap for what would amount to peanuts, securing what is truly a world class data set and a platform that would seem to be more valuable in the hands of a large company with the resources to sell large projects to governments.  Somebody like an IHS comes to mind.

Pacific Biosciences

This investment idea is a little out of my normal area of expertise and consistent with my desire to expand my investing horizons.   Its an idea I came up with after reading  this Seeking Alpha article which I think does a good job explaining the trend we are trying to jump on.

PACB has 74 million shares outstanding, so at $5.20 (where I bought it) the market capitalization is $385mm.   The company has $79 million of  cash and investments and $14 million in debt.

They are in the business of gene sequencing.  Pacific Biosciences sells gene sequencing machines and related consumables for running tests to map an individuals gene in hopes of detecting a mutation that will diagnose the future susceptibility to disease.  The machine of course is a one-time sale but the consumables are a recurring revenue stream so the business has a bit of a razor-blade type revenue model to it.

The big player in the gene sequencing arena is a company called Illumina.  This is a $30 billion market cap company that did nearly $2 billion in revenue last year.  They dwarf Pacific Biosciences, which did around $60 million of revenue last year.

In fact I read that Pacific Biosciences has only sold around 150 machines.  One interesting thing from their presentation is that for each of the machines Pacific Biosciences sells, they generate about $120,000 of consumable sales a year.   Thus the opportunity for significantly higher recurring revenues is there if they can sell a few more machines.

What seems to set Pacific Biosciences apart from Illumina is that their technology produces much longer gene sequencing strings which results in far lower error rates.  Below is a comparison between the two.

comparisonilluminaOne thing I am not sure of is where Pacific Biosciences sits compared to some of their non-public competition.  I was reading through some of the comments on a site called Stock Gumshoe that suggested that some private competition may have as good or better sequencing technology.

Pacific Biosciences also has an agreement whereby Roche will market their product for the diagnostics market in 2013.  In May Pacific Biosciences met the second milestone of that agreement.  The only thing that is a little disconcerting about this agreement is that Pacific Biosciences did not announce how much revenue they would be giving up once (and if) the product is commercialized.

My bottom line is that there are enough interesting things going on for me to speculate in the stock.  The key word being speculate.  There is a chance of wider adoption, there is a chance of an expansion of their relationship with Roche, there is maybe even an outside chance of a takeover.  And its an industry that is clearly growing, is in investor favor, and the stock was at a 52-week low when I bought it.

But I will flatly state that I would not take my comments about Pacific Biosciences too seriously.  My knowledge of this industry remains weak (though its improving as I read more).  They could be, or maybe even have been, surpassed by competition and I would not be the first to know.  So we’ll see how this goes and chalk up any loss to the cost of education.

Portfolio Composition

Click here for the last four weeks of trades.

week-210

Week 197: “Make your money while you can”

Portfolio Performance

week-197-yoyperformance

week-197-Performance

See the end of the post for the current make up of my portfolio and the last four weeks of trades

Monthly Review and Thoughts

On Thursday, while I was surfing around the web over lunch hour trying to figure out what I wanted to write about this month, I stumbled on a YouTube clip of Neil Young being interviewed on Charlie Rose. He describes what he thinks of Bob Dylan’s song writing (the quote in the title of this post is attributable to the Dylan song Rambling, Gambling Willie).  Young observes the source of inspiration that leads to a great song.

The argument about whether investing is an art, a science, or just a mundane business is one that depends as much on who is making the argument as it does on an objective reduction of its reality.  Investing has elements of all three and it’s essence is whatever one associates with best.  I stand firmly in the camp that it is an art, and I think that for the kind of shooting star sort of performance I try to achieve it is that hard to put your finger on source of inspiration that leads to out-performance.

Maybe I am being too bold to analogize the making of a great song and the development of a great investment idea but as I stand back from both I do note some common characteristics. Both tend to be built on their historical predecessors, both stand in deference to the structure they abide in and, when done correctly, both live within the bounds of their genre’s common sense.  At the same time each has to extend outside of that imposed limit just enough to see what is not easily seen, but not so far as to drop off the cliff of abstraction or dogma.

Most importantly though is that both are built upon a sensibility, one that is hard to put your finger on but nevertheless is there.  Being more of a word guy, I can describe this best with lyrics; when you hear something that is right, you just know it, even though you might not know why.  You can try to break it down to the linguistic structures, cultural context and the feelings it invokes, but I don’t think you will ever quite get to understanding.  The right phrase in the right spot is right because it just clearly is, and if you happen to be possessed by the inspiration that Neil Young describes you will discern that and act accordingly.

The sensibility on which an investing idea is based is no less complicated, no less abstract, and I would argue no less difficult to reduce down to its essence.  But if you are in the groove, you just know that a good idea is good before you even know why.

Two Interesting BNN Segments… the first on the market

I listen to a lot of BNN clips.  I will have them on in the background as I’m doing research.  Most of it is not helpful and I’ve become deft at tuning out the noise.  But every so often I hit upon a gem.  I came across a couple of those in the last month, with the first being this segment on market performance.

I can’t figure out how to embed a BNN video for the life of me so here is the link to the segment.

The theme is the performance of small cap stocks, and in it Jonathan Golub describes his thoughts on the small cap sector.  The really interesting part is in the last minute, where Golub notes that in the average year that the economy is not in a recession you will see 16-18% gains in the stock market.  But when we hit a recession you “lose all your chips” and the average loss is 35%.

A couple of points here.  First, this exemplifies something I have been saying, that one has to get while the getting is good but be ready to get out when it ends.  There is no hiding when the tide goes out.

Second, this is relevant to what we are seeing right now.  All of the gnashing of teeth over valuations and the lack of a correction forgets that the stock market rarely makes a sustained move down when the economy is expanding.  But once the economy begins to contract the moves down are exaggerated when compared to the amplitude change in growth.

In the mean time there are always ways to justify valuation. Right now the most common one is that with interest rates low, inflation expectations non-existent, so ergo a future dollar is worth more than it has been in the past.  Therefore, paying a higher multiple for that future dollar of earnings is justified.  This logic, which like all justifications contains both germs of truth and seeds of failure, can be used to rationalize stock prices to these levels and probably a lot further.

… and the second on oil

Over the last couple of months I have picked away at position in oil stocks on weakness and at this point have accumulated positions of a decent size in RMP Energy (RMP), Rock Energy (RE), Canaco (CNE), Jones Energy (JONE) and most recently DeeThree Energy (DTX).

There are still plenty of analysts and much of the twitter universe posturing for a further decline in oil and with it a commensurate drop in the oil stocks.  I don’t know about oil, it may fall if the storage concerns are real, or it may not, but I do think that barring some further shock (ie. a demand shock brought on by a recession) we have seen the lows in the stocks.

It doesn’t make sense to me that oil stocks (at least the one’s I own) will fall to new lows even if the price of oil does drop further.  I understand there are leveraged companies that can ill afford further whittling of their cash flow and for those names sure I can see further declines.  But for well capitalized companies, I just don’t buy the idea that further panic will engulf them and send them down further.

To think that is to embrace the idea that an oil stock price should be based on the current price of oil.  That’s crazy.  Nothing in the stock market is priced off of current prices.  If it was, shipping stocks would be trading at 3-4x what they are, Pacific Ethanol would have gotten to $50 for crashing all the way back down to $5, I could go on.  Oil stocks, like everything else, go up and down based on the expectation of future business.

Turning again to a BNN clip, Eric Nuttall was on Market Call last week and he had some interesting observations about the oil market.

The four important data points that Nuttall provides are:

  1. US company capital expenditures are expected to be down 40-50% in 2015.
  2. Production has already seen monthly declines in Eagleford and Bakken
  3. The natural decline in the US is 2mbbl/d per year
  4. Weatherford was recently quoted of  saying that international capital expenditures have fallen by 20-25% and that as a result they expect production ex-US and ex-Canada will fall by 1.5mmbbl/d in 2016

I think there is a growing understanding that prices are too low to support stable production levels worldwide and that we will soon (in the next 9 months) see the impact of this as supply turns down.  Without getting into too many details, I have seen enough declines of Eagleford and Bakken wells to know that these fields are not eternal springs of flowing oil.  We are already seeing the first signs of declines in these fields.  And the natural gas analogy is flawed; there is no such thing as associated oil, so there will be no analogy to the associated gas (and of course the Marcellus) that led to the strong production from natural gas even as rig counts fell.

What I find ironic is that many of the same names who derided oil companies for not producing free cash at $100 are somehow confident that production will remain high at $50.  It seems like a rather bizarre confluence of opinion to me.

But most investors are beginning to realize that well financed oil companies will soon be making significantly more cash flow than what is implied by plugging in the current spot.  So I don’t think we see new lows in names like those I own, or if we do it is going to be an operational catalyst (see RMP Energy for an unfortunate example), not a general malaise.

Portfolio changes

I did not make a lot of portfolio changes over the last month.  The few things I did do was to add two more shipping companies to my basket of tanker stocks, and a cheap little hotel REIT trading well under net asset value.  I will discuss each below:

Ardmore Shipping

As I watch my tanker trade finally start to pay off, in the last month I added three new tanker stocks, Euronav (EURN), Tsakos Energy (TNP) and Ardmore Shipping (ASC).   There was a good Seeking Alpha article on Tsakos, which is available here, and I’m still stepping through my research into Euronav, so I will focus my discussion here on Ardmore.

Both Ardmore and Tsakos allowed me to dip my toes into the product tanker market.  Up until now I have focused my purchases on crude tanker companies.  However, with oil prices low demand for oil products (gasoline, heating oil, jet fuel and the various chemical product inputs) should be strong.  While Tsakos Energy has a diversified fleet with 30 crude tankers and 29 product tankers, Ardmore is a pure play on the product tanker market with a fleet consisting of only MR tankers.

In addition to the demand story, Ardmore listed the following reasons to expect strengthening demand in the product tanker market.

demanddynamic

The following chart is from the Capital Product Partners corporate presentation, and it illustrates the extent to which point 2 from above is asserting itself:

USexportsOn the supply side, Ardmore sees demand outstripping supply in the medium term:

supplydynamic

So the supply/demand situation is favorable.  But what really drew me to Ardmore is their valuation.  The company provided the following charts on Page 7 of their January presentation.

earningspotential

Right now MR spot rates are above $23,000 per day.  From the above slide, the company is saying they expect to earn at least $2.55 per share with rates at current level, and the stock trades at a little more than $10.

Ardmore owns and operates exclusively MR2 tankers (mid-range tankers).  They have a fleet of 24 tankers including 10 new builds that will delivered throughout this year.  The fleets average age is only 4 years.  Their operating fleet is almost entirely on spot or short term charter.

fleetWhile Ardmore looks cheap on an earnings basis they are also reasonable on a net asset value basis.  According to their January presentation Ardmore is priced at a 20% discount to net asset value.

I still like the crude tanker story more than the product tanker story, and indeed my bet on tankers is severly skewed to the crude tanker side (I know, DHT, TNK, EURN, FRO, and NAT on the curde side).  Nevertheless I do think there is upside in both and that Ardmore is a solid way to play the product tanker side.

Capital Product Partners

While Capital Products Partners was one of the first tanker stocks I bought, but I haven’t written much about them and so, since I’m talking about the product tanker market in this post, I wanted to give them a bit of space here.

Capital Product Partners differs from the other tanker plays that I own in that it is not a direct play on the spot market.  Every vessel that the company owns is chartered out for the long term, with some of those charters lasting upwards of 10 years.  Capital Product Partners also differs from the other positions in that it is a dividend play.   The company distributes virtually all of its available cash flow in dividends and markets itself to dividend investors.

Yet even though the company has very little exposure to the spot rate, I still look at this as a play on nearterm tanker market fundamentals.  The idea here is that as rates prove themselves durable, investors will become more comfortable with the dividend sustainability of the company and perhaps anticipate increases to the dividend.  The shift in sentiment should lead to capital appreciation, which when combined with the 10% dividend that the company pays will need to a nice overall return.

Capital Product Partners is primarily levered to the product market.  In all they have 18 product tankers, 4 suezmax tankers, 7 containers and 1 capesize dry bulk vessel all with period employment.  Their fleet is fairly young with an average age of 6.5 years (their MR fleet is on average 8.3 years old). In addition they have 3 container vessels and 2 MR tankers being delivered in 2015, all of which will be on long term contract:

newvessels

In their corporate presentation, the company provides a chart giving some historical perspective to current MR rates.  As you can see, MR spot rates are higher now than they have been in some time, and since the chart was published, rates have gone higher still and are now in the $25,000 per day range:

MRspotBelow is a table illustrating the expiry of charters for Capital Product Partners.  Notice how the expiry of most of the product tankers occurs in 2015, which should result in rate hikes to the majority of the renewals, whereas the containerships and the dry bulk vessel, for which the market is currently in excess and rates very soft, are chartered for years in advance.

charters

I have some questions about the long-term sustainability of the dividend, but I don’t think I will be sticking around long enough in the stock to warrant too much consternation over them.  They’ve been paying a dividend for a while, so from that perspective things look good,  but I still am uneasy over the long term in the same way that I am around many of these capital intensive businesses: Asset purchases are lumpy and large and so free cash generation follows suit which makes it really difficult to discern exactly what the average free cash is over the long term.

For example cash flow from operations over the last 3 years has been $125mm, $129mm and $85mm respectively.  Vessel acquisition and advances less proceeds has been: $30mm, $331mm and -$20mm (in this year dispositions exceeded acquisitions and thus resulting in negative overall expenditures). Clearly the company’s free cash has whipped wildly over this time.   Taking the three year period fas a whole, free cash (before dividend) has been essentially nil at -$2 million.

Now some might look at this as a red flag and something to be avoided, but I think it fits quite well into the thesis (which is short enough in duration to not worry too much about the long-term sustainability).  No doubt investors are assigning the 10% dividend in part because they are evaluating the same free cash flow numbers I am and questioning the sustainability of that dividend.  If however charter rates do show themselves to stay high for the short-term (lets say the next 12 months), this concern will be alleviated and backward looking free cash flow models will be thought to be inadequately pricing in what will come to be viewed (by some at least) as a secular change in rates.

Whether the rate change will be truly secular is up for debate; I really have no idea what rates will be in 2 years let alone the 10 or 20 years relevant for modeling Capital Product Partners sustainability and I think that anyone who does better have called the downturn in the oil price 2 years in advance to have credibility in that prediction.

What I do know is that when the price of a commodity changes, even if turns out to be for a short time, there consensus perception of that commodity shifts at the margins, and that shift in perception can make very large differences in the valuations of those equities priced off of the commodity.  Such is the nature of the world we live in and rather than gnashing one’s teeth at the uncertainty, better to take advantage of it and make a few bucks on the euphoria.

Sotherly Hotels

I have been on the look-out for some safer investments.  As much as I enjoy speculating in tankers and airlines and oils, these remain short-term plays.  I doubt I will have investment in more than one or two of these stocks in a years time.

I came across Sotherly from a SeekingAlpha article available here.  Its written by Philip Mause, whom I have been following for a while and of whom I have gotten a number of solid income oriented investment ideas from.

The income angle of Sotherly is modest, the company pays about a 3.5% dividend, but they have a exemplary habit of increasing that dividend on a quarterly basis. I’m also pretty sure they could pay out a significantly higher dividend if they chose to. The dividend amounts to about 25% of AFFO, and they expect AFFO to grow from $1.09 per share in 2014 to $1.21 in 2015.

The stock trades at a significant discount to other hotel operators as the chart below illustrates.

comparison

I think that the reason the stock trades at such a discount is its size; with 10.5 million shares outstanding and another 2.55 million units, at $7.74 the market cap of Sotherly’s is only about $101 million.  Volume is typically light and so its too small and too illiquid for most institutions.  But the smallish dividend likely limits its attractiveness to the retail contingent.  It is in this no-mans land that there is the opportunity.

The company’s stable of hotels is situated across the south east United States:

hotels

In total these hotels have a total of 3,009 rooms.  Looking at this on a standard EV/room basis, rooms are priced at $112,662 per room, which isn’t particularly cheap.  However this is mitigated by fact that these are mostly high-end hotels – ADR and RevPAR are quite high:

hotels2

On an EV/EBITDA the stock trades at 11.7x and on FFO basis they trade at 5.7x.  The company guided AFFO for 2015 of $1.24 per share and on the conference call when confronted with some discrepancy in the high and low estimates for their AFFO guidance they were forced to admit that they were being conservative on the high end.  Again turning the the company presentation, they put the “inherent value of assets” at over $17 per share:

NAV

On the last conference call management was adament that they would not issue equity at these prices and that they would need to see at least $10 before reconsidering that position.  While they have some exposure to Texas, thus far occupancy does not seem too impacted by oil and many of their larger corporate customers are not oil related.  I’m not sure what else to write about this one.  Its a solid hotel operator trading at a discount to peers for not a very good reason.  As long as the economy  remains sound I think the stock slowly walks up to the double digits over the rest of the year.

Impac Mortgage

I’ve gotten a bunch of questions in emails about Impac Mortgage.  So yes, I have bought back Impac, I took a tiny position around $9 and added to it at $11.  But its a small position and I haven’t talked about it on the blog or on twitter. The reason?  I really don’t know how this plays out, so my thesis is pretty weak.

The company is doing some interesting things.  They have a deal with Macqaurie for the purchase of their non-QM originations and they bought out a fairly large online origination business called CashCall.  So they are doing something, and the share price is reacting.  Still, I find it hard to quantify what it all means for the fair value of the stock. So I really dont know what I’m buying.

If you look at the recent financials and they aren’t great, so the bet I’m making here is kind of a bet that Impac is going to use these pieces and become a big non-compliant originator but while that qualitatively seems like a sound thesis, I don’t really know what numbers they will be able to churn out. To put it another way I probably wouldn’t have bought the stock if I didn’t have a history of it and some comfort that Tomkinson seems pretty experienced and can put something together.  So I own the stock but probably won’t talk about it any more unless something happens to clarify the situation.

What I sold

Midway Gold

My Midway Gold sale wasn’t quite as bad as it looks.  I forgot to sell my holdings in the practice portfolio account and  by the time I realized this the stock had tanked to under 30 cents.  So my sale looks particularly ill timed.

Nevertheless I sold Midway at a loss after the company announced delays with Pan, a potential cash shortfall and some early problems with grade.  The company realized news in its March update that one of the water wells malfunctioned so it has taken them longer to fill up the tailings pond and that Pan would not see the first gold pour until the end of the month, delayed from early March estimates.  Worryingly the company had drawn $47.5 million of its $53 million lending facility and was under negotiations with its lenders to fund working capital requirements.  To make matters worse early results showed some grade discrepancies with their model as grades were coming in lower.

Of all the news, it was the grade discrepancies that led me to sell.  If it hadn’t been for that I would have chalked it up to early days mining hiccups that they would eventually struggle through.  But until the grade issue is resolved you just don’t know what you are getting.  So I had to sell.

Nationstar Mortgage

As I wrote in my comment section last month, I didn’t talk about Nationstar because the stock was a trade that I didn’t expect to hold very long.  As it turned out, I held it hardly any time at all, selling the stock in the day following the posting of my last post.  Nationstar was down below $26 when I bought it and I sold it at around $30, so I made a little profit on the transaction.

I bought the stock because I thought there were some tailwinds here in Q1: the company said on their fourth quarter conference call that so far in first quarter originations were strong.  They also expected amortization to be lower in the first quarter, which will boost earnings.  Nationstar also has a reasonable non-HARP business so they don’t face quite the pressure Walter Asset Management does at that winds down and that, combined with the evolving travails at Ocwen, might bring marginal dollars into the stock from investors looking for the one remaining non-bank servicer without significant regulatory risk (or at least so it appears).   Nevertheless I figured the move from $26 to $30 was probably too far too fast so I took my quick profit.  I have been thinking about buying back in for another run now that is again languishing in the mid-$20’s.

Final Thoughts

I waited three months for it but the tanker trade is upon us.

Portfolio Composition

Click here for the last four weeks of trades.

week-197

Week 185 Just your run-of-the-mill Portfolio Update

Portfolio Performance

week-185-yoyperformance

week-185-Performance

See the end of the post for the current make up of my portfolio and the last four weeks of trades

I don’t have any general comments to make so I am going to get right into my portfolio updates for the last month.

The Tanker trade

The biggest moves in my portfolio have tended to take place in the first couple months of the year .  In 2013 it was YRC Worldwide.  In 2014 it was Pacific Ethanol.  I’m hoping that this year its the tanker stocks.

Of course the tanker stocks have already had significant moves.  I have been adding positions at prices that are much higher than they were a couple of months ago.  But to use Pacific Ethanol as an analogy, the move from $2 to $4 was only the first act.  I’m not sure if these stocks will put on the show that Pacific Ethanol did, but I am hopeful there is  a second act in the cards. Read more